EUVIMEDEUVIMED entdecken
Crossref

3C3 alleviates atopic dermatitis-like phenotypes through cyclophilin A and B-mediated inhibition of calcineurin-NFAT pathway

Yejin Jo, Hayan Jeong, Su-Jin Lee, Jangho So, Seung-Heon Yoo, Soonnam Kim, Suyoung Go, Jee Yoon Shin, Yul Lee, Dong-Sik Shin, Seok-In Kim, Yoon-Sik Lee und 1 weitere

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yejin Jo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Stress-Responding Biomaterial Center, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul 04107, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Cyclophilin A, Cyclophilins, Anti-Inflammatory Agents. Die Arbeit nennt 76 Literaturangaben. Gefördert von: Korea Evaluation Institute of Industrial Technology, Ministry of Education, Ministry of Trade, Industry and Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) disrupts a patients' quality of life and is associated with other atopic disorders, such as food allergy, allergic rhinitis, and asthma. Although topical medications are widely used, they have undesirable side effects, suggesting the need for treatments with improved efficacy and safety. In this study, we identified 3C3 as a candidate compound for AD treatment using in vitro TNFα-treated HaCaT keratinocytes and a DNFB-induced AD mouse model. 3C3 treatment alleviated AD-like phenotypes and suppressed the gene activation of pro-inflammatory cytokine. We further found that 3C3 binds to cyclophilin A (CypA) and cyclophilin B (CypB), inhibiting the phosphatase activity of calcineurin. 3C3 treatment suppressed the nuclear translocalization and occupancy of NFAT2 and NFAT4 at gene promoters of IL-6, IL-13, IL-31, and IL-33 in PAR2 activated HaCaT keratinocytes. This resulted in suppression of PAR2 agonist-induced gene activation of IL-6, IL-13, IL-31, and IL-33. In addition, unlike glucocorticoids, 3C3 did not induce skin atrophy through upregulation of REDD1 and reduction of mTOR signaling. Our study suggests that 3C3 may help alleviate skin inflammatory diseases including AD, through a mechanism similar to that of cyclosporine A, whose use is limited due to side effects such as nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicCyclophilin ACyclophilinsAnti-Inflammatory AgentsAnimalsHumansCalcineurinNFATC Transcription FactorsSignal TransductionKeratinocytesMiceDisease Models, AnimalCytokinesPhenotypeSkinHaCaT CellsCell LineMice, Inbred BALB C

Stichwörter der Autor:innen

3C3Atopic dermatitisCalcineurinCyclophilinCyclosporine aNFAT

Substanzen

CalcineurinNFATC Transcription FactorsCyclophilin ACyclophilinscyclophilin BCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Life Science, Stress-Responding Biomaterial Center, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul 04107, Republic of Korea.
  • Kainos Medicine Inc, 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, Republic of Korea.
  • Genome Data Integration Centre, Syntekabio Inc., Daejeon, 34025, Republic of Korea.
  • Department of Chemical and Biological Engineering, Sookmyung Women's University, Seoul 04310, Republic of Korea.
  • BeadTech Inc. 10-dong 4th, 49 Wonsi-ro, Danwon-gu, Ansan-si, Gyeonggi-do 15610, Republic of Korea.
  • Department of Life Science, Stress-Responding Biomaterial Center, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul 04107, Republic of Korea. Electronic address: bgju@sogang.ac.kr.

Förderung

  • Korea Evaluation Institute of Industrial Technology
  • Ministry of Education
  • Ministry of Trade, Industry and Energy

Zitieren

APA

Jo, Y., Jeong, H., Lee, S. J., So, J., Yoo, S. H., Kim, S., Go, S., Shin, J. Y., Lee, Y., Shin, D. S., Kim, S. I., Lee, Y. S., & Ju, B. G. (2025). 3C3 alleviates atopic dermatitis-like phenotypes through cyclophilin A and B-mediated inhibition of calcineurin-NFAT pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115335

Vancouver

Jo Y, Jeong H, Lee SJ, So J, Yoo SH, Kim S, et al. 3C3 alleviates atopic dermatitis-like phenotypes through cyclophilin A and B-mediated inhibition of calcineurin-NFAT pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115335

BibTeX
@article{Jo2025,
  author = {Jo, Yejin and Jeong, Hayan and Lee, Su-Jin and So, Jangho and Yoo, Seung-Heon and Kim, Soonnam and Go, Suyoung and Shin, Jee Yoon and Lee, Yul and Shin, Dong-Sik and Kim, Seok-In and Lee, Yoon-Sik and Ju, Bong-Gun},
  title = {3C3 alleviates atopic dermatitis-like phenotypes through cyclophilin A and B-mediated inhibition of calcineurin-NFAT pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115335}
}
Kostenlos starten →